RxDoctor Payments Data

Joanne Yen

Physician Assistant · Dallas, TXNPI 1356671101

Payments from drug & device makers

$4,405in general payments, 2019–2025

Across 190 payments — averaging $23.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avadel CNS Pharmaceuticals, LLC$599
  • Axsome Therapeutics, Inc.$590
  • Boehringer Ingelheim$355
  • Harmony Biosciences LLC$349
  • Indivior Inc.$302
  • AbbVie$208
  • plus $2K from 29 others

What the payments were for

  • Consulting fees$2005%
  • Food & beverage$4,11593%
  • Education$902%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,405 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$19,923
JardianceEmpagliflozin13$14,016
VascepaIcosapent Ethyl12$10,600
Lidocaine11$1,592
Gabapentin31$650
Atorvastatin Calcium57$526
Albuterol Sulfate HfaAlbuterol Sulfate11$448
Pramipexole DihydrochloridePramipexole Di-Hcl17$439
Levothyroxine Sodium31$395
Valsartan13$377
Zolpidem Tartrate26$281
Tamsulosin Hcl21$281
Amlodipine Besylate46$255
Olmesartan Medoxomil11$236
Lisinopril26$232

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$25$19,92321 claims
Boehringer IngelheimJardiance$355$14,01613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →